Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Depression 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 910 Carboplatin 788 pembrolizumab 747 Paclitaxel 744 Bevacizumab 716 Cisplatin 709 Gemcitabine 621 Docetaxel 584 Rituximab 558 Radiotherapy 548 Dexamethasone 511 Nivolumab 491 Doxorubicin 445 Fluorouracil 392 Capecitabine 382 Etoposide 358 Pemetrexed 339 Cytarabine 335 Oxaliplatin 335 Lenalidomide 328 Prednisone 327 Erlotinib Hydrochloride 323 fludarabine phosphate 316 Trastuzumab 305 Leucovorin 299 fludarabine 296 Vincristine 288 Bortezomib 284 Filgrastim 284 Cetuximab 277

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Typhoid-Paratyphoid Vaccines × Clear all

NCT02415387 2024-07-24

IMPACT

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed

172 enrolled 14 charts

Breast Neoplasms, Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡